Scopelianos Angelo

Chief R&D Officer at AXGN

Sold, on record
$63k
Dollars the filings state
Form 4 sales
2
Latest Mar 21, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AXGNAxogen, Inc.Chief R&D Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale AXGNPlan not stated
    Dec 29 2020

    Sold 567 shares at $17.81 ($10k)

    Scopelianos Angelo, VP Research & Development

    Sold 9.3% of holdings ($109k position)5,529 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AXGNNo plan
    Mar 21 +1178 days

    Sold 6,881 shares at $7.68 ($53k)

    Scopelianos Angelo, Chief R&D Officer

    No 10b5-1 planSold 10.6% of holdings ($498k position)57,994 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Scopelianos Angelo
Source
Mar 21, 2024AXGNChief R&D OfficerForm 4 sale6,881$53k10.6%No planSEC
Dec 29, 2020AXGNVP Research & DevelopmentForm 4 sale567$10k9.3%Plan not statedSEC